4 in stock
Mutagenic Labz LGD3303 is one of the newer SARMs on the market and purported to be one of the best SARMs for overall sheer mass and strength gains. LGD-3303 is also known for providing a noticeable muscular fullness despite being a dry compound. LGD-3303 offers superb oral bioavailability. It is non-steroidal and is ingested orally. It binds to the androgen receptor with an extremely high affinity and selectivity, and once it does this it exerts exceptional anabolic effects in muscle and bone, equating to a large increase in muscle size and strength. The androgenic effects in the body are minimal at the effective dosage for muscle building purposes, thus making it a very promising SARM.
Mutagenic Labz LGD3303 is one of the newer SARMs on the market and purported to be one of the best SARMs for overall sheer mass and strength gains. LGD-3303 is also known for providing a noticeable muscular fullness despite being a dry compound. LGD-3303 is non-steroidal, is ingested orally and offers superb oral bioavailability.
Mutagenic Labz LGD3303 binds to the androgen receptor with an extremely high affinity and selectivity and once it does this it exerts exceptional anabolic effects in muscle and bone. This equates to a large increase in muscle size and strength. The androgenic effects in the body are minimal at the effective dosage for muscle building purposes, making it a very promising SARM.
1 serving contains 5mg LGD3303 and 5mg of Piperine.
LGD-3303 shares a very similar chemical structure to LGD-4033, which is a far more mainstream and popular SARM notorious for its fantastic mass building properties. The difference lies in how the two affect prostate weight and muscle gain. The androgenic impact on the body is minimal with LGD-3303. This means that the drug is safe and it has fewer or no side effects even at high dosage. It is yet to be ascertained if LGD-3303 is as effective as LGD-4033 in the impact on muscle gain. Initial research indicates that LGD-3303 would be as effective as LGD-4033, if not more.
Unlike LGD-4033, LGD-3303 is typically regarded as a dry compound; hence there is a far greater likelihood that it will not blur muscle definition in a cutting phase. LGD-3303 is not only strong enough to retain your hard-earned muscle in a caloric deficit but it will not cause water retention. It will not hinder the cosmetic appearance of your physique in any way.
It could be argued that in a bulking phase LGD-4033 may be a better choice as it may provide the beneficial joint fluid that will decrease the risk of injury as your strength levels increase but this would be personal preference.
What you can expect from Mutagenic Labz LGD3303 is a fairly substantial boost in lean, dry mass gains, with a considerable increase in strength and muscular endurance. The consensus on LGD-3303 is that substantial results can be expected at doses of about 10mg or higher. The sweet spot may be closer to the 20mg range.
In clinical studies, a dose of 1mg per kilogram was a sufficient dose to completely replace the anabolic support provided by natural testosterone production in terms of muscle growth. This would equate to a dosage of roughly 11mg in humans. It doesn’t matter if the research subject is on an empty stomach or not during the administration of LGD-3303.
Mutagenic Labz LGD-3303 contributes to recognizable muscular fullness because of its impact on nitrogen retention. The drug can partition nutrients and increase retention of nitrogen which makes muscles fuller. The impact on the size of muscles is visible in just a few days. In short, this SARM will help your muscles to be more pronounced or well defined. The definition of your muscles would not get blurred after you complete the course which is a concern with many other SARMs.
The half-life of LGD-3303 is 6 hours. This means that you ‘ll have to use the dosage noted above twice a day for the best results.
Due to the short half-life, you have to split the daily dosage to two or three times. Only such an approach would have a sustainable impact on endurance and strength of your muscles. Other SARMs with such a short half-life must also be taken twice or thrice.
The recommended dosage is around 10-20mg per day. If you are going for three times a day then split them in the morning, midday and evening. Keep the interval consistent. Many people have already reported that a higher dosage of up to twenty milligrams per day has a much better impact. You can try around 20mg per day but be consciously observant so you can identify any side effects. There is no major side effect but some people may respond differently, especially when the dose is increased.
LGD-3303 is a little more suppressive than other SARMs. While most SARMs do have a suppressive tendency, LGD-3303 would cause a substantial change in how much testosterone is secreted every day. It is possible there will be a substantial effect on testosterone production. Therefore, you will need a post cycle therapy.
Complete the course of Mutagenic Labz LGD-3303 and begin a post cycle therapy to restore the optimum levels of testosterone production. Some people may not choose a post cycle therapy. This is acceptable since the suppression of the sex hormone is only temporary. SARMs like LGD 3303 do not have any medium-term or long-term side effects. The testosterone secretion can be restored naturally but it may take longer so a post cycle therapy is often recommended.
If you observe or feel some changes to your libido or sex drive during the course or after, do not worry about it since it is only normal. There have been cases wherein LGD 3303 has increased libido and people have enjoyed the enhanced sex drive. There are people who have experienced a decline in libido. This effect or its nature is not universal. The effect may be completely undone after the course or it may take a while. This is why a post cycle therapy is necessary and must be chosen on the basis of personal experience rather than what others are doing. SARMs do work in a predictable manner but people will not respond in the same way.
Although human trials have not yet begun, the medical community considers that this drug can help in the treatment of some serious conditions.
Firstly, it can stimulate aspects of female sexual behaviour and can potentially serve as a potential therapy for women with sexual desire disorders. In fact, according to research conducted in 2010 at the University of Arizona College of Medicine, this selective androgen receptor enhances male-directed sexual preference in female rats.
At the moment, this SARM is being tested for its potential as an osteoporosis treatment. Since osteoporosis leads to bone weakness and increased danger of bones breaking, it makes sense that a SARM like this can have the potential to relieve symptoms. Its potential to maintain lean tissues and muscles among the aged can prevent numerous medical problems and improve quality of life.
Moreover, according to recent animal studies, LGD 3303 enhances the effectiveness of bisphosphonate drugs. These drugs prevent the loss of bone density and are used to treat osteoporosis and similar conditions.
LGD-3303 has been developed to help address a wide range of conditions. However, the most important is its ability to maintain the beneficial effects of androgens in improving muscle mass and bone density without side effects. Although the selective mechanism of LGD-3303 and other SARMs is not yet clearly understood even with ongoing research, it is clearly a big leap from the usual anabolic steroids. Once LGD-3303 is injected into the body or taken orally, it will trigger androgenic action on a cellular level.
However, it should be remembered that the human body contains millions of cells and a substance that triggers androgenic effects in each of these cells would have devastating side effects. That is why LGD-3303 is termed as selective. Instead of triggering androgenic action in all cells, it will only target muscle tissue and skeletal cells.
This is the main reason why LGD-3303 has been used as a supplement in bodybuilding and also as a possible treatment for people who have issues with bone density. LGD-3303 could also have other positive benefits. However, because the drug is still under research, these potential benefits are not yet clear.